Trial in progress update on ENGOT-cx8/GOG-3024/innovaTV 205: Addition of a new cohort with first-line (1L) tisotumab vedotin (TV) plus pembrolizumab (pembro) plus carboplatin (carbo) +/- bevacizumab (bev) in recurrent/metastatic cervical cancer (r/mCC)

Thumbnail
Date
2022
Author
Vergote, Ignace
Mirza, Mansoor Raza
Sehouli, Jalid
Lorusso, Domenica
Ose, Fatih K.
Cibula, David
Westermann, Anneke M.
Collins, Dearbhaile Catherine
Banerjee, Susana N.
Oaknin, Ana
Soumaoro, Ibrahima
Jain, Shweta
Monk, Bradley J.
Metadata
Show full item record
URI
http://hdl.handle.net/11727/8010
Collections